References
- Aktas, Z., Kayacan, C. B., Schneider, I., Can, B., Midilli, K. & Bauernfeind, A. (2008). Chemotherapy, 54,101–106.
- Anon. (2005). Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute.
- Brown, D. F. J. & Brown, L. (1991). Journal of Antimicrobial Chemotherapy, 27,185–190.
- Carrër, A., Poirel, L., Eraksoy, H., Cagatay, A. A., Badur, S. & Nordmann, P. (2008). Antimicrobial Agents and Chemotherapy, 52,2950–2954.
- Carrër, A., Poirel, L., Yilmaz, M., Arikan Akan, O., Feriha, C., Cuzon, G., Matar, G. M., Honderlick, P. & Nordmann, P. (2010). Antimicrobial Agents and Chemotherapy, 54,1312–1309.
- Cuzon, G., Naas, T., Bogaerts, P., Glupczynski, Y., Huang, T. D. & Nordmann, P. (2008). Antimicrobial Agents and Chemotherapy, 52,3463–3464.
- Gülmez, D., Woodford, N., Palepou, M. F., Mushtaq, S., Metan, G., Yakupogullari, Y., Kocagoz, S., Uzun, O., Hascelik, G. & Livermore, D. M. (2008). International Journal of Antimicrobial Agents, 31, 523–526.
- Kanj, S. S., Corkill, J. E., Kanafani, Z. E., Araj, G. A., Hart, C. A., Jaafar, R. & Matar, G. M. (2008). Clinical Microbiology and Infection, 14, 501–504.
- Leavitt, A., Navon-Venezia, S., Chmelnitsky, I., Schwaber, M. J. & Carmeli, Y. (2007). Antimicrobial Agents and Chemotherapy, 51, 3026–3029.
- Matar, G. M., Cuzon, G., Araj, G. F., Naas, T., Corkill, J., Kattar, M. M. & Nordmann, P. (2008). Clinical Microbiology and Infection, 14, 887–888.
- Naas, T., Zerbib, M., Girlich, D. & Nordmann, P. (2003). Antimicrobial Agents and Chemotherapy, 47, 19–26.
- Poirel, L., Pitout, J. D. & Nordmann, P. (2007). Future Microbiology, 2,501–512.